Stock really needs to start getting some top line growth. FCF over twelve months is pretty disappointing, R&D requirement still so significant
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025